CML

(redirected from chronic myelocytic leukemia)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to chronic myelocytic leukemia: myelogenous, chronic granulocytic leukemia

CML

Capital Market Line

In the capital asset pricing model, a line that plots the extra return an investor expects for each change in the level of risk. Rational investors expect higher returns for riskier assets and the capital market line shows this graphically. A portfolio that accurately reflects the capital market line is considered a Markowitz efficient portfolio. The slope of the capital market line is a calculation of the equilibrium market price of risk. See also: Beta.
References in periodicals archive ?
The report provides a snapshot of the global therapeutic landscape of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
It also reviews key players involved in the therapeutic development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia).
The report provides comprehensive information on the therapeutics under development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
An Overview of Pipeline Products for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
The clinical trial report, Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, Q4, 2010" provides data on the Chronic Myelocytic Leukemia (CML) clinical trial scenario.
Chronic Myelocytic Leukemia Pipeline Review, Q4 2010, provides an overview of the Chronic Myelocytic Leukemia therapeutic pipeline.

Full browser ?